Vertex

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated Vertex logo

E_DEPRECATED Error in file �functions_general.php� at line 186: Function utf8_encode() is deprecated

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For five years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.

Keywords:

Date	News
2020-01-08	Vertex to Present at the J.P. Morgan Healthcare Conference on January 13
2019-12-13	Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Comb...
2019-12-10	Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to...
2019-11-20	French Authorities Approve National Reimbursement of ORKAMBI (lumacaftor/ivacaftor) for Eligible People Ages Two and Old...
2019-11-20	French Authorities Approve National Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) for Eligible People Ages Two and Ol...
2019-11-19	CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investiga...
2019-11-18	Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to E...
2019-11-13	Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines
2019-11-12	Vertex Confirms Northern Ireland Offer Accepted for Cystic Fibrosis Medicines
2019-11-07	Vertex to Present at the Credit Suisse Healthcare Conference on November 12

Date

News

2020-01-08

Vertex to Present at the J.P. Morgan Healthcare Conference on January 13

2019-12-13

Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Comb...

2019-12-10

Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to...

2019-11-20

French Authorities Approve National Reimbursement of ORKAMBI (lumacaftor/ivacaftor) for Eligible People Ages Two and Old...

2019-11-20

French Authorities Approve National Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) for Eligible People Ages Two and Ol...